Macrogenics (MGNX) Cash from Operations (2012 - 2026)
Macrogenics' (MGNX) quarterly Cash from Operations came in at 35811000.0 in Q1 2026, up 23.63% year-on-year from 28966823.47 in Q1 2025, and down 183.24% on a QoQ basis from 43021000.0 in Q4 2025.
Macrogenics (MGNX) Cash from Operations (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Cash from Operations data on file, last reported at 35811000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 23.63% year-over-year to 35811000.0 in Q1 2026; TTM through Mar 2026 was 69961000.0, a 0.49% change from a year earlier, with the FY2025 full-year figure at 81040000.0, down 18.53% from the prior year.
- Cash from Operations for Q1 2026 stood at 35811000.0, down from 43021000.0 in the prior quarter.
- Over the last five years, Cash from Operations for MGNX reached as high as 60162000.0 in Q3 2024 and fell as low as 57696000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 20611058.82 across 5 years, with a median of 35246000.0 in 2023.
- On a YoY basis, Cash from Operations climbed as much as 270.69% in 2024 and fell as far as 2029.49% in 2024.
- Year by year, Cash from Operations stood at 29320000.0 in 2022, then plunged by 195.62% to 28037000.0 in 2023, then tumbled by 36.99% to 38407000.0 in 2024, then jumped by 212.01% to 43021000.0 in 2025, then slumped by 183.24% to 35811000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 35811000.0 in Q1 2026, 43021000.0 in Q4 2025, and 30186000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | -35.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.81 Mn |
| Mar 31, 2026 | -35.81 Mn |
| Dec 31, 2025 | 43.02 Mn |
| Dec 31, 2025 | 43.02 Mn |
| Sep 30, 2025 | -30.19 Mn |
| Sep 30, 2025 | -30.19 Mn |
| Jun 30, 2025 | -46.99 Mn |
| Jun 30, 2025 | -46.99 Mn |
| Mar 31, 2025 | -46.89 Mn |
| Mar 31, 2025 | -46.89 Mn |
| Dec 31, 2024 | -38.41 Mn |
| Dec 31, 2024 | -38.41 Mn |
| Sep 30, 2024 | 60.16 Mn |
| Sep 30, 2024 | 60.16 Mn |
| Jun 30, 2024 | -44.49 Mn |
| Jun 30, 2024 | -44.49 Mn |
| Mar 31, 2024 | -45.64 Mn |
| Mar 31, 2024 | -45.64 Mn |
| Dec 31, 2023 | -28.04 Mn |
| Dec 31, 2023 | -28.04 Mn |